Blood Test Spots Ovarian Cancer Risk Years Early
Blood Test Spots Ovarian Cancer Risk Years Early
Blood Test Spots Ovarian Cancer Risk Years Early
Key points
اہم نکات
मुख्य बातें
- A blood test detected a hidden warning sign of ovarian cancer in 92.3% of women who had it, in a study published in Nature Medicine.
- Researchers at the Hoag Family Cancer Institute found raised blood levels of an RNA molecule called Tu-Stroma in women with a precancerous change in the fallopian tubes, and the test correctly cleared 98.2% of healthy women in a validation group.
- The eight-year international study looked at stored blood samples from 506 people, and the signal outperformed the standard CA125 test.
- A blood test detected a hidden warning sign of ovarian cancer in 92.3% of women who had it, in a study published in Nature Medicine.
- Researchers at the Hoag Family Cancer Institute found raised blood levels of an RNA molecule called Tu-Stroma in women with a precancerous change in the fallopian tubes, and the test correctly cleared 98.2% of healthy women in a validation group.
- The eight-year international study looked at stored blood samples from 506 people, and the signal outperformed the standard CA125 test.
- A blood test detected a hidden warning sign of ovarian cancer in 92.3% of women who had it, in a study published in Nature Medicine.
- Researchers at the Hoag Family Cancer Institute found raised blood levels of an RNA molecule called Tu-Stroma in women with a precancerous change in the fallopian tubes, and the test correctly cleared 98.2% of healthy women in a validation group.
- The eight-year international study looked at stored blood samples from 506 people, and the signal outperformed the standard CA125 test.
A blood test detected a hidden warning sign of ovarian cancer in 92.3% of women who had it, in a study published in Nature Medicine. Researchers at the Hoag Family Cancer Institute found raised blood levels of an RNA molecule called Tu-Stroma in women with a precancerous change in the fallopian tubes, and the test correctly cleared 98.2% of healthy women in a validation group. The eight-year international study looked at stored blood samples from 506 people, and the signal outperformed the standard CA125 test. The test is not available to patients yet and still needs trials in women followed over time.
A blood test detected a hidden warning sign of ovarian cancer in 92.3% of women who had it, in a study published in Nature Medicine. Researchers at the Hoag Family Cancer Institute found raised blood levels of an RNA molecule called Tu-Stroma in women with a precancerous change in the fallopian tubes, and the test correctly cleared 98.2% of healthy women in a validation group. The eight-year international study looked at stored blood samples from 506 people, and the signal outperformed the standard CA125 test. The test is not available to patients yet and still needs trials in women followed over time.
A blood test detected a hidden warning sign of ovarian cancer in 92.3% of women who had it, in a study published in Nature Medicine. Researchers at the Hoag Family Cancer Institute found raised blood levels of an RNA molecule called Tu-Stroma in women with a precancerous change in the fallopian tubes, and the test correctly cleared 98.2% of healthy women in a validation group. The eight-year international study looked at stored blood samples from 506 people, and the signal outperformed the standard CA125 test. The test is not available to patients yet and still needs trials in women followed over time.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।